Facchetti I, Grandi M, Cucchi P, Geroni C, Penco S, Vigevani A
Farmitalia-Carlo Erba srl, Erbamont Group, Milan, Italy.
Anticancer Drug Des. 1991 Nov;6(5):385-97.
Quantitative structure-activity relationship studies aimed at improving drug activity profiles require the determination of the physicochemical properties possibly involved in biological action. The lipophilic character of selected anthracyclines has been measured by means of reverse-phase high performance liquid chromatography, selecting appropriate experimental conditions. The capacity coefficients at zero percentage of the organic phase (log K0), which are retention indexes, have been used as lipophilicity descriptors in a QSAR study, involving as biological data the cytotoxicity of anthracyclines in a doxorubicin-sensitive (LoVo) and in a doxorubicin-resistant (LoVo/Dx) human cell lines. The results obtained in these in vitro models indicate that lipophilicity plays a role in anthracycline activity, influencing drug availability at the site of action.
旨在改善药物活性谱的定量构效关系研究需要测定可能参与生物作用的物理化学性质。通过反相高效液相色谱法,并选择合适的实验条件,测定了所选蒽环类药物的亲脂性。在零有机相百分比时的容量系数(log K0),即保留指数,已被用作定量构效关系研究中的亲脂性描述符,所涉及的生物学数据是蒽环类药物在对多柔比星敏感的(LoVo)和对多柔比星耐药的(LoVo/Dx)人细胞系中的细胞毒性。在这些体外模型中获得的结果表明,亲脂性在蒽环类药物活性中起作用,影响药物在作用部位的可及性。